Ultra-Early Vasopressin Shows Promise in Septic Shock, But Randomized Trial Evidence Still Missing
A new target trial emulation links ultra-early vasopressin initiation to lower mortality in septic shock, but randomized trial evidence remains ...
A new target trial emulation links ultra-early vasopressin initiation to lower mortality in septic shock, but randomized trial evidence remains ...
A new editorial argues the Surviving Sepsis Campaign must evolve beyond survival metrics to align sepsis care with patient goals, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine